相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。ECCO Guidelines on Therapeutics in Crohn's Disease: Medical Treatment
Joana Torres et al.
JOURNAL OF CROHNS & COLITIS (2020)
Increased Discontinuation Rates of Anti-TNF Therapy in Elderly Inflammatory Bowel Disease Patients
M. E. de Jong et al.
JOURNAL OF CROHNS & COLITIS (2020)
On-Treatment Decrease of Serum Interleukin-6 as a Predictor of Clinical Response to Biologic Therapy in Patients with Inflammatory Bowel Diseases
Gian Paolo Caviglia et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Optimising PLGA-PEG Nanoparticle Size and Distribution for Enhanced Drug Targeting to the Inflamed Intestinal Barrier
Lauren J. Mohan et al.
PHARMACEUTICS (2020)
Oral delivery of anti-TNF antibody shielded by natural polyphenol-mediated supramolecular assembly for inflammatory bowel disease therapy
Xinyu Wang et al.
THERANOSTICS (2020)
Novel polyurethane-based nanoparticles of infliximab to reduce inflammation in an in-vitro intestinal epithelial barrier model
Ritesh M. Pabari et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2019)
British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults
Christopher Andrew Lamb et al.
GUT (2019)
Remicade® (infliximab): 20 years of contributions to science and medicine
Richard Melsheimer et al.
BIOLOGICS-TARGETS & THERAPY (2019)
DrugBank 5.0: a major update to the DrugBank database for 2018
David S. Wishart et al.
NUCLEIC ACIDS RESEARCH (2018)
Pre-adsorption of antibodies enables targeting of nanocarriers despite a biomolecular corona
Manuel Tonigold et al.
NATURE NANOTECHNOLOGY (2018)
Infliximab restores colonic barrier to adherent-invasive E-coli in Crohn's disease via effects on epithelial lipid rafts
Olena Yakymenko et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2018)
Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 2: Current Management
Marcus Harbord et al.
JOURNAL OF CROHNS & COLITIS (2017)
T cell-targeting nanoparticles focus delivery of immunotherapy to improve antitumor immunity
Daniela Schmid et al.
NATURE COMMUNICATIONS (2017)
The association of tissue anti-TNF drug levels with serological and endoscopic disease activity in inflammatory bowel disease: the ATLAS study
Andres J. Yarur et al.
GUT (2016)
Self assembled hyaluronic acid nanoparticles as a potential carrier for targeting the inflamed intestinal mucosa
Seyed Yaser Vafaei et al.
CARBOHYDRATE POLYMERS (2016)
Effect of Thermal and Shear Stressors on the Physical Properties, Structural Integrity and Biological Activity of the Anti-TNF-alpha Monoclonal Antibody, Infliximab
Jihad A. Alsaddique et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2016)
Direct effect of infliximab on intestinal mucosa sustains mucosal healing: exploring new mechanisms of action
Valentina Petito et al.
DIGESTIVE AND LIVER DISEASE (2016)
Gastrointestinal stability of therapeutic anti-TNF α IgG1 monoclonal antibodies
Vipul Yadav et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2016)
Encapsulation-free controlled release: Electrostatic adsorption eliminates the need for protein encapsulation in PLGA nanoparticles
Malgosia M. Pakulska et al.
SCIENCE ADVANCES (2016)
Systematic Review of Effects of Withdrawal of Immunomodulators or Biologic Agents From Patients With Inflammatory Bowel Disease
Joana Torres et al.
GASTROENTEROLOGY (2015)
Infliximab-Related Infusion Reactions: Systematic Review
Lev Lichtenstein et al.
JOURNAL OF CROHNS & COLITIS (2015)
Systematic review with network meta-analysis: the efficacy of anti-TNF agents for the treatment of Crohn's disease
R. W. Stidham et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2014)
Comparative evaluation of novel biodegradable nanoparticles for the drug targeting to breast cancer cells
C. Mattu et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2013)
PEG-functionalized microparticles selectively target inflamed mucosa in inflammatory bowel disease
Christian Lautenschlaeger et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2013)
Mechanism of transport of saquinavir-loaded nanostructured lipid carriers across the intestinal barrier
Ana Beloqui et al.
JOURNAL OF CONTROLLED RELEASE (2013)
Clinical Use and Mechanisms of Infliximab Treatment on Inflammatory Bowel Disease: A Recent Update
Yuan Guo et al.
BIOMED RESEARCH INTERNATIONAL (2013)
Stability of infliximab in polyvinyl chloride bags
Ryuji Ikeda et al.
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2012)
Anti-TNF-α antibodies improve intestinal barrier function in Crohn's disease
Rainer Noth et al.
JOURNAL OF CROHNS & COLITIS (2012)
Inflammatory parameters in Caco-2 cells: Effect of stimuli nature, concentration, combination and cell differentiation
Jacqueline Van De Walle et al.
TOXICOLOGY IN VITRO (2010)
Cytokine regulation of tight junctions
Christopher T. Capaldo et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2009)
Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts
Martin Lundqvist et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Determination of drug permeability and prediction of drug absorption in Caco-2 monolayers
Ina Hubatsch et al.
NATURE PROTOCOLS (2007)
Downregulation of epithelial apoptosis and barrier repair in active Crohn's disease by tumour necrosis factor α antibody treatment
S Zeissig et al.
GUT (2004)
Optimizing anti-TNF treatment in inflammatory bowel disease
P Rutgeerts et al.
GASTROENTEROLOGY (2004)
分享论文
